Connection
Robert MacLaren to Dose-Response Relationship, Drug
This is a "connection" page, showing publications Robert MacLaren has written about Dose-Response Relationship, Drug.
|
|
Connection Strength |
|
 |
|
 |
|
0.163 |
|
|
|
-
Mueller SW, Preslaski CR, Kiser TH, Fish DN, Lavelle JC, Malkoski SP, MacLaren R. A randomized, double-blind, placebo-controlled dose range study of dexmedetomidine as adjunctive therapy for alcohol withdrawal. Crit Care Med. 2014 May; 42(5):1131-9.
Score: 0.086
-
Horinek EL, Kiser TH, Fish DN, MacLaren R. Propylene glycol accumulation in critically ill patients receiving continuous intravenous lorazepam infusions. Ann Pharmacother. 2009 Dec; 43(12):1964-71.
Score: 0.063
-
Owen PS, Golightly LK, MacLaren R, Ferretti KA, Badesch DB. Formulary management of recombinant factor VIIa at an academic medical center. Ann Pharmacother. 2008 Jun; 42(6):771-6.
Score: 0.014